Abstract
The rapid understanding of the cellular and molecular bases of organ function and disease processes will be translated in the next decade into new therapeutic approaches to a wide range of clinical disorders, including acute and chronic renal failure. Central to these new therapies are the developing technologies of cell therapy and tissue engineering, which are based on the ability to expand stem or progenitor cells in tissue culture to perform differentiated tasks and to introduce these cells into the patient either via extracorporeal circuits or as implantable constructs. Cell therapy devices are currently being developed to replace the filtrative, metabolic, and endocrinologic functions of the kidney lost in both acute and chronic renal failure. This review summarizes the current state of development of a wearable or implantable bioartificial kidney. These devices have the promise to be combined to produce a wearable or implantable bioartificial kidney for full renal replacement therapy that may significantly diminish morbidity and mortality in patients with acute or chronic kidney disease.
Similar content being viewed by others
References
Pino CJ, Humes HD (2010) Stem cell technology for the treatment of acute and chronic renal failure. Transl Res 156(3):161–168
Fissell WH, Fleischman AJ, Humes HD, Roy S (2007) Development of continuous implantable renal replacement: past and future. Transl Res 150(6):327–336
Johnston K, Humes HD (2011) Extracorporeal renal replacement. In: Principles of regenerative medicine, second edition. Elsevier, Ann Arbor, MI, pp. 943–953
Roy S, Goldman K, Marchant R, Zydney A, Brown D, Fleischman A, Conlisk A, Desai T, Duffy S, Humes H, Fissell W (2011) Implanted renal replacement for end-stage renal disease. Panminerva Med 53(3):155–166
MacKay SM, Funke AJ, Buffington DA, Humes HD (1998) Tissue engineering of a bioartificial renal tubule. ASAIO J 44:179–183
Nikolovski J, Gulari E, Humes HD (1999) Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant 8(4):351–364
Humes HD, Cieslinski DA (1992) Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res 201:8–15
Humes HD, Krauss JC, Cieslinski DA, Funke AJ (1996) Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus. Am J Physiol 271(40):F42–F49
O’Neil JJ, Stegemann JP, Nicholson DT, Mullon CJ-P, Maki T, Monaco AP, Solomon BA (1997) Immunoprotection provided by the bioartificial pancreas in a xenogeneic host. Transplant Proc 29:2116–2117
Humes HD, MacKay SM, Funke AJ, Buffington DA (1999) Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 55:2502–2514
Humes HD, Buffington DA, MacKay SM, Funke AJ, Weitzel WF (1999) Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 17:451–455
Breen D, Bihari D (1998) Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness. Kidney Int 66(Suppl):S25–S33
Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 103:565–575
Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338:777–783
Fissell WH, Dyke DB, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM, Humes HD (2002) Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals. Blood Purif 20:55–60
Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD (2003) Bioartificial kidney ameliorates Gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 14:454–461
Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH (2003) Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Crit Care Med 31:2421–2428
Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, Sobota J (2004) Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 66:1578–1588
Tumlin J, Wali R, Brennan K, Humes HD (2008) Efficacy and safety of renal tubule therapy for acute renal failure. J Am Soc Nephrol 19:1034–1040
Humes HD, Sobota JT, Ding F, Song JH, The RAD Investigator Group (2010) A selective cytopheretic inhibitory device (SCD) to treat the immunologic dysregulation of acute and chronic renal failure. Blood Purif 29:183–190
Ding F, Yevzlin AS, Humes HD (2010) A selective cytopheretic inhibitory device (SCD) accelerates renal recovery and improves mortality in ICU patients with AKI and MOF in an exploratory clinical study. ASAIO J 56:140
Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, Dasilva JR, Astor BC, Yevzlin AS, Humes HD (2012) The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study. Semin Dial. doi:10.1111/sdi.12032
Pino CJ, Yevzlin AS, Lee K, Westover AJ, Smith PL, Buffington DA, Humes HD (2013) Cell-based approaches for the treatment of systemic inflammation. Nephrol Dial Transplant 28(2):296–302
Orive G, Hernández RM, Gascon AR, Calafiore R, Chang TM, DeVos P, Hortelano G, Hunkeler D, Lacík I, Shapiro AM, Pedraz JL (2003) Cell encapsulation: promise and progress. Nat Med 9:104–107
Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029–1034
Westover AJ (2012) Enhanced propagation of adult human renal epithelial progenitor cells to improve cell sourcing for tissue-engineered therapeutic devices for renal disease. J Tissue Eng Regen Med 6(8):589–597
Buffington DA, Pino CJ, Hageman GM, Chen L, Humes HD (2012) Bioartificial renal epithelial cell systems (BRECS): a compact, cryopreservable extracorporeal renal replacement device. Cell Transplant. doi:10.3727/215517911X653328
Pino CJ, Humes HD (2011) Bioartificial kidney: comprehensive biomaterials, vol 6. Elsevier, Oxford
Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019
Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107–114
Gura V, Beizai M, Ezon C, Polaschegg HD (2005) Continuous renal replacement therapy for end-stage renal disease. The wearable artificial kidney (WAK). Contrib Nephrol 149:325
Roberts M, Ash SR, Lee DB (1999) Innovative peritoneal dialysis: flow-thru and dialysate regeneration. ASAIO J 45(5):372–378
Westover A, Buffington D, Jung J, Lou L, Rojas A, Charles L, Smith P, Johnston K, Pino C, Humes D (2010) Uremic ovine model of end-stage renal disease (ESRD) for the evaluation of the bioartificial renal epithelial cell system (BRECS) 3(abstract). J Am Soc Nephrol 21:201
Ash SR, Janie EM (1997) Continuous flow-through peritoneal dialysis (CFPD) comparison of efficiency to IPD, TPD, and CAPD in an animal model. Perit Dial Int 17:365–372
Ronco C, Davenport A, Gura V (2008) A wearable artificial kidney: dream or reality? Nat Clin Pract Nephrol 4:604–605
Kanani DM, Fissell WH, Roy S, Dubnisheva A, Fleischman A, Zydney AL (2010) Permeability-selectivity analysis for ultrafiltration: effect of pore geometry. J Membr Sci 349:405–410
Fissell WH, Dubnisheva A, Eldridge AN, Fleischman AJ, Zydney AL, Roy S (2009) High-performance silicon nanopore hemofiltration membranes. J Membr Sci 326:58–63
Groszek J, Li L, Ferrell N, Smith R, Zorman CA, Hofmann CL, Roy S, Fissell WH (2010) Molecular conformation and filtration properties of anionic Ficoll. Am J Physiol Renal Physiol 299:F752–F757
Muthusubramaniam L, Lowe R, Fissell WH, Li L, Marchant RE, Desai TA, Roy S (2011) Hemocompatibility of silicon-based substrates for biomedical implant applications. Ann Biomed Eng 39(4):1296–1305
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Humes, H.D., Buffington, D., Westover, A.J. et al. The bioartificial kidney: current status and future promise. Pediatr Nephrol 29, 343–351 (2014). https://doi.org/10.1007/s00467-013-2467-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-013-2467-y